Upfront versus resection after neoadjuvant chemotherapy for pancreatic adenocarcinomas with venous contact: comparative analysis of operative and survival outcomes.

Date publication

février 2022

Journal

Surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Dr AVEROUS Gerlinde , Pr BACHELLIER Philippe

Tous les auteurs :
Addeo P, Cususmano C, Dufour P, Avérous G, Bachellier P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35232605

Résumé

Neoadjuvant treatment before resection for pancreatic adenocarcinoma having contact with the splenomesentericoportal venous axis could improve the results of extended pancreatectomies. We compared the outcomes of upfront (UR) and resection after neoadjuvant chemotherapy (NAC) for pancreatic adenocarcinoma.

Référence

Surgery. 2022 Feb 26;: